eISSN: 3023-6940
  • Home
  • The evaluation of 200 pnl procedure results which was made by an experienced and inexperienced surgeons in two different periods at the same clinic

Original Research

The evaluation of 200 pnl procedure results which was made by an experienced and inexperienced surgeons in two different periods at the same clinic


1 Van Bölge Eğitim ve Araştırma Hastanesi

2 Ümraniye Eğitim ve Araştırma Hastanesi


DOI :
2016; 11 (2): 06-13

Abstract

Objective: This study aimed to evaluate the value of direct and indirect markers showing inf- lammation in the diagnosis of Brucella epidid- ymo-orchitis (BEO) and its differentiation from non-Brucella epididymo-orchitis.

Material and Methods: A total of 152 pa- tients that presented to our clinic with acute sc- rotal complaints and were diagnosed with epidid- ymo-orchitis between January 2015 and January 2019 were retrospectively evaluated. Excluded from the study were 15 patients with a hemato- logic disease, coronary artery disease or malig- nant diagnosis, eight patients aged below 18 years, and 13 patients whose hemogram and C-reactive protein (CRP) values were not available in their medical records. The diagnosis of epididymo-or- chitis was based on laboratory (leukocytosis, CRP elevation) and radiological findings. The diagnosis of BEO was defined as ≥1/160 titer value and/or positive blood culture in the standard tube aggluti- nation (STA) test in addition to orchitis symptoms and signs.

Results: The median WBC (p=0.033), neut- rophil (p=0.013) and monocyte (p=0.006) counts and NL (p=0.014) and ML (p=0.002) ratios were statistically significantly lower in the BEO group. The ML ratio had the highest predictive value with an AUC of 0.725 (95% CI = 0.146-0.424; p=0.002), as well as high specificity (97.3%) and diagnostic accuracy (83.5%) in predicting a BEO diagnosis. No parameter was an independent factor in the differentiation of BEO and NBEO.

Conclusions: Easy, fast and low-cost hemoto- logical inflammatory markers provide diagnostic benefits complementing serological tests in dis- tinguishing BEO from NBEO cases. In particular, MLR has a high diagnostic accuracy compared to other parameters.

Keywords: Brucella, epididymo-orchitis, in- fectious diseases, monocyte/lymphocyte ratio
 


Abstract

Objective: This study aimed to evaluate the value of direct and indirect markers showing inf- lammation in the diagnosis of Brucella epidid- ymo-orchitis (BEO) and its differentiation from non-Brucella epididymo-orchitis.

Material and Methods: A total of 152 pa- tients that presented to our clinic with acute sc- rotal complaints and were diagnosed with epidid- ymo-orchitis between January 2015 and January 2019 were retrospectively evaluated. Excluded from the study were 15 patients with a hemato- logic disease, coronary artery disease or malig- nant diagnosis, eight patients aged below 18 years, and 13 patients whose hemogram and C-reactive protein (CRP) values were not available in their medical records. The diagnosis of epididymo-or- chitis was based on laboratory (leukocytosis, CRP elevation) and radiological findings. The diagnosis of BEO was defined as ≥1/160 titer value and/or positive blood culture in the standard tube aggluti- nation (STA) test in addition to orchitis symptoms and signs.

Results: The median WBC (p=0.033), neut- rophil (p=0.013) and monocyte (p=0.006) counts and NL (p=0.014) and ML (p=0.002) ratios were statistically significantly lower in the BEO group. The ML ratio had the highest predictive value with an AUC of 0.725 (95% CI = 0.146-0.424; p=0.002), as well as high specificity (97.3%) and diagnostic accuracy (83.5%) in predicting a BEO diagnosis. No parameter was an independent factor in the differentiation of BEO and NBEO.

Conclusions: Easy, fast and low-cost hemoto- logical inflammatory markers provide diagnostic benefits complementing serological tests in dis- tinguishing BEO from NBEO cases. In particular, MLR has a high diagnostic accuracy compared to other parameters.

Keywords: Brucella, epididymo-orchitis, in- fectious diseases, monocyte/lymphocyte ratio